header logo image


Page 670«..1020..669670671672..680690..»

How an Arthritis Drug Could Treat Coronavirus Infections – American Council on Science and Health

March 8th, 2020 10:42 am

Why do microbes kill some people but not others? This is the hardest question in all of medical microbiology. The reason it's so hard is because the answer depends not just on the microbe in question but also on the person.

Sometimes, it's because the microbe is particularly nasty. No matter how healthy a person is, smallpox, HIV, Ebola, cholera, and plague all wreak havoc on the human body.

But that's not the case for all microbes. Billions of people get scratched every year, but only a handful will develop an infection with a flesh-eating bacterium. Millions of people go swimming in lakes every year, but only a handful will become infected with a brain-eating parasite. Why? Is it simply "wrong place, wrong time," or is there a more sophisticated answer?

Increasingly, the latter appears to be true. As a case-in-point, scientists discovered that a single mutation (i.e., a single letter change in our 3-billion-letter genome) may have doubled a person's risk of becoming infected with the 2009 pandemic strain of influenza. In other words, an individual's genetics -- particularly when it comes to genes involved with the immune system (as was the case in the flu research) -- may be just as much to blame as the microbe's genetics.

How an Arthritis Drug Could Treat Coronavirus Infections

An effective immune response must be of the proper strength and directed at an appropriate target. If these two criteria aren't met, bad things can happen, such as autoimmune disease or a lethal over-reaction to a peanut. The same is true when the immune system targets a dangerous microbe. The response must not be too weak or too strong. If it's too weak, the microbe will overcome the body; if it's too strong, the body can suffer from collateral damage.

One way collateral damage can occur is when the immune system sends out too many pro-inflammatory signals. The immune system is constantly "talking" to other parts of the immune system using chemical messengers known as cytokines. Some encourage inflammation, others discourage it. If too many pro-inflammatory cytokines, such as one called interleukin-6 (IL-6) are released, a "cytokine storm" is said to have developed.

Typically, IL-6 is deployed in order to elicit a quick response to infection and tissue injury. But if too much is produced, the entire body can undergo an inflammatory response, which can be lethal if it leads to multiple organ failure. Ultimately, it's this sort of system-wide immunological overreaction that causes people to die from septic shock. It may also be responsible for some of the deaths due to influenza and SARS.

Something similar may be happening with people who become infected with the Wuhan coronavirus and develop the disease now known as COVID-19. Perhaps they have an immunogenetic profile that, for some reason, overreacts to the virus. Thus, a drug that targets IL-6 could, in theory, help block an overreactive immune response.

And that's precisely what China has just discovered. An antibody drug that blocks IL-6 receptors (called Actemra or tocilizumab) has shown promise in treating patients in Chinese clinics. FiercePharma explains that this drug was approved by the FDA in 2017 to treat cytokine storms and in 2010 to treat rheumatoid arthritis, an autoimmune condition. What causes that? You guessed it: Too much IL-6.

Let's hope this drug helps save some lives.

See the original post here:
How an Arthritis Drug Could Treat Coronavirus Infections - American Council on Science and Health

Read More...

Ultra-Processed Food Consumption Linked to Cardiovascular Risk in RA – The Cardiology Advisor

March 8th, 2020 10:42 am

Higher levels of consumption of ultra-processed food in patients with rheumatoid arthritis (RA) have been associated with worse metabolic profiles and elevated cardiovascular risk, while higher levels of consumption of unprocessed or minimally processed foods are associated with lower low density lipoprotein (LDL) cholesterol and reduced 10-year cardiovascular disease risk, according to study results published in Clinical Rheumatology.

To assess the associations between processed food consumption and risk factors for cardiovascular disease in patients with RA, investigators in Sao Paulo, Brazil, conducted a cross-sectional study with 56 women (aged 62.57.9 years; body mass index, 28.45.1 kg/m2) focused on evaluation of food consumption according to level of processing (eg, unprocessed or minimally processed, processed, and ultra-processed) and associated levels of consumption of processed foods with risk factors for cardiovascular disease.

Unprocessed or minimally processed was the most prevalent food processing level in the study participants (42.612.6% of total energy intake [TEI]), followed by processed (24.211.9% TEI), ultra processed (18.111.8% TEI), and culinary ingredients (15.16.4% TEI). Adjusted regression models showed a negative association between higher consumption of unprocessed or minimally processed foods and Framingham risk score (=-0.07 [95% CI, -0.14 to -0.006]; P =.034), 10-year risk of developing cardiovascular disease ( =-0.07 [95% CI, -0.12 to -0.02]; P =.013) and LDL (=-1.09 [95% CI, -1.94 to -0.24]; P =.014). A positive association was found between higher consumption of ultra processed foods and glycated hemoglobin (=0.04 [95% CI, 0.01-0.07]; P =.013). After adjustments were made for age and body mass index, the association between unprocessed or minimally processed foods and Framingham risk score was no longer significant. In contrast, after adjustments, the association between higher consumption of ultra processed foods and Framingham risk score became significant (=0.06 [95% CI, 0.001-0.11]; P =.045).

Study investigators concluded, Patients with RA consuming more ultra-processed foods showed higher glycated hemoglobin and Framingham risk score, whereas those consuming more unprocessed or minimally processed foods had lower 10-year risk of developing cardiovascular disease and LDL. A food pattern characterized by a high ultra-processed food consumption emerges as a novel, modifiable risk factor for cardiovascular diseases in RA. Prospective, controlled studies should address this hypothesis.

Reference

Smaira FI, Mazzolani BC, Peanha T, et al. Ultra-processed food consumption associates with higher cardiovascular risk in rheumatoid arthritis [published online January 4, 2020]. Clin Rheumatol. doi:10.1007/s10067-019-04916-4

This article originally appeared on Rheumatology Advisor

Read more:
Ultra-Processed Food Consumption Linked to Cardiovascular Risk in RA - The Cardiology Advisor

Read More...

Rising arthritis: Shalby hospital to come up in UP – United News of India

March 8th, 2020 10:42 am

More News08 Mar 2020 | 4:31 PM

Puducherry, Mar 8 (UNI) Mr M Sankaranarayanan, Managing Director, The Grand Technologies and Founder-cum-Chairman of Aathmalayaa School, Karaikal has been elected as the Chairman of Confederation of Indian Industry (CII), Puducherry State Council for the financial year 2020-21.

Ahmedabad, Mar 8 (UNI) Jewelry sector expert and the Chairman and Managing Director (CMD) of Headway Business Solutions LLP, Gujarat based company in to consultancy, coaching and mentoring for jewelry sector business development, Paresh Rajpara on Sunday said that the biggest challenge in the gems and jewelry sector in India was the gold price volatility.

BEIJING, March 8, 2020 /PRNewswire/ -- Forty-eight hours ahead of schedule, Sinopec Corp, China's leading energy and chemical company, put its first melt-blown non-woven fabric assembly line into operation at its Yanshan factory in Beijing on March 6. The Yanshan factory is a converted 3600 square meter old warehouse that has found new life as a global production base following the challenges brought by the coronavirus outbreak.

NEW DELHI, India, March 7, 2020 /PRNewswire/ -- IPM India Wholesale Trading Private Ltd (IPM India), a country affiliate of Philip Morris International Incorporation (PMI), has announced that it has set an aim to achieve as much as 40% equal gender representation in management roles in the company by 2022. A more focused journey began for IPM India in 2015 with the introduction of target Gender Representation KPIs. The company took a firm decision to take up the gender representation KPI from 18 percent in 2015 to 40 percent by 2022.

Kolkata, Mar 07 (UNI) Abhijit Roy, Managing Director and CEO of Berger Paints India Ltd., has been elected as the chairman of CII Eastern Region for 2020 21.

See the rest here:
Rising arthritis: Shalby hospital to come up in UP - United News of India

Read More...

Diabetes – World Health Organization

March 7th, 2020 2:53 pm

What is diabetes?

Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. Hyperglycaemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's systems, especially the nerves and blood vessels.

In 2014, 8.5% of adults aged 18 years and older had diabetes. In 2016, diabetes was the direct cause of 1.6 million deaths and in 2012 high blood glucose was the cause of another 2.2 million deaths.

Type 1 diabetes (previously known as insulin-dependent, juvenile or childhood-onset) is characterized by deficient insulin production and requires daily administration of insulin. The cause of type 1 diabetes is not known and it is not preventable with current knowledge.

Symptoms include excessive excretion of urine (polyuria), thirst (polydipsia), constant hunger, weight loss, vision changes, and fatigue. These symptoms may occur suddenly.

Type 2 diabetes (formerly called non-insulin-dependent, or adult-onset) results from the bodys ineffective use of insulin. Type 2 diabetes comprises the majority of people with diabetes around the world, and is largely the result of excess body weight and physical inactivity.

Symptoms may be similar to those of type 1 diabetes, but are often less marked. As a result, the disease may be diagnosed several years after onset, once complications have already arisen.

Until recently, this type of diabetes was seen only in adults but it is now also occurring increasingly frequently in children.

Gestational diabetes is hyperglycaemia with blood glucose values above normal but below those diagnostic of diabetes, occurring during pregnancy.

Women with gestational diabetes are at an increased risk of complications during pregnancy and at delivery. They and their children are also at increased risk of type 2 diabetes in the future.

Gestational diabetes is diagnosed through prenatal screening, rather than through reported symptoms.

Impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG) are intermediate conditions in the transition between normality and diabetes. People with IGT or IFG are at high risk of progressing to type 2 diabetes, although this is not inevitable.

Over time, diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves.

Simple lifestyle measures have been shown to be effective in preventing or delaying the onset of type 2 diabetes. To help prevent type 2 diabetes and its complications, people should:

Early diagnosis can be accomplished through relatively inexpensive testing of blood sugar.

Treatment of diabetes involves diet and physical activity along with lowering blood glucose and the levels of other known risk factors that damage blood vessels. Tobacco use cessation is also important to avoid complications.

Interventions that are both cost-saving and feasible in developing countries include:

Other cost saving interventions include:

WHO aims to stimulate and support the adoption of effective measures for the surveillance, prevention and control of diabetes and its complications, particularly in low and middle-income countries. To this end, WHO:

The WHO "Global report on diabetes" provides an overview of the diabetes burden, the interventions available to prevent and manage diabetes, and recommendations for governments, individuals, the civil society and the private sector.

The WHO "Global strategy on diet, physical activity and health" complements WHO's diabetes work by focusing on population-wide approaches to promote healthy diet and regular physical activity, thereby reducing the growing global problem of overweight people and obesity.

* Defined as fasting blood glucose equal to or higher than 7 mmol/L, or on medication for raised blood glucose, or with a history of diagnosis of diabetes.

** High blood glucose is defined as a distribution of fasting plasma glucose in a population that is higher than the theoretical distribution that would minimize risks to health (derived from epidemiological studies). High blood glucose is a statistical concept, not a clinical or diagnostic category.

(1) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration.

Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio et al. Lancet. 2010; 26;375:2215-2222.

(2) Causes of vision loss worldwide, 1990-2010: a systematic analysis.Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H et al. Lancet Global Health 2013;1:e339-e349

(3) 2014 USRDS annual data report: Epidemiology of kidney disease in the United States.United States Renal Data System. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014:188210.

Read this article:
Diabetes - World Health Organization

Read More...

Eating oranges may be the key to losing weight, study finds – Yahoo News

March 7th, 2020 2:53 pm

Oranges could be great for losing weight, study suggests (Getty Images)

Eating oranges could be the route to losing weight, staying slim and preventing diabetes, new research has found.

This works due to a chemical found in oranges and tangerines called nobiletin.

Nobiletin may even have the ability to reverse obesity and unclog arteries.

In the experiment by the University of Western Ontario, mice were fed the substance and turned out to be leaner and healthier as a result.

The researchers are now conducting the same experiment using humans.

Read more: Waist circumference is vital sign and should be measured

Dr Murray Huff, who has been studying nobiletin's effects for over a decade, was pleased with the research.

We've shown that in mice that already have all the negative symptoms of obesity, we can use nobelitin to reverse those symptoms, and even start to regress plaque build-up in the arteries, known as atherosclerosis.

This means that nobelitin could be essential in reversing symptoms of obesity in its tracks.

How this super compound works is still shrouded in mystery, though.

The researchers originally thought the molecule was likely acting on the pathway that regulates how fat is handled in the body, called AMP Kinase.

This enzyme turns on the machinery in the body that burns fats to create energy, and it also blocks the manufacture of fats.

However, during further tests on mice without AMP Kinase, the nobiletin still had a positive affect.

Read more: Four in five children arent exercising enough, WHO finds

While the way nobiletin is working in the body remains a mystery, Dr Huff was pleased that it didnt work through AMP Kinase.

It shows that nobiletin won't interfere with other drugs that act on the AMP Kinase system, which currently include diabetes medicines like metformin.

The team will now move onto trialling this on human beings.

If its successful, this could provide us with a beneficial way to tackle obesity - a major burden to the healthcare system.

Obesity and its resulting metabolic syndromes are a huge burden to our health care system, and we have very few interventions that have been shown to work effectively.

We need to continue this emphasis on the discovery of new therapeutics.

The rest is here:
Eating oranges may be the key to losing weight, study finds - Yahoo News

Read More...

Diabetes Health Type 1: Food Additives Linked to Rise in Autoimmune Diseases – Diabetes Health

March 7th, 2020 2:53 pm

By Tanya Caylor

Type 1 diabetes is increasing at a rate of 3 percent per year. Cases of rheumatoid arthritis are rising only slightly less quickly, at least among women, at a rate of 2.5 percent per year. Celiac disease is four times more common now than half a century ago.

What do these statistics have in common? All three are part of an overall increase in autoimmune disorders, which now affect more than 23 million Americans and rank as the third most common type of chronic illness, surpassed only by heart disease and cancer. Scientists have identified at least 80 distinct types of disease in which the body seemingly turns on itself, attacking its own tissue. While the three mentioned above are among the most common, researchers suspect there may be dozens more yet to be discovered.

Though the exact cause of autoimmune disease, in all its many forms, remains unknown, it is suspected that a virus or something in the patients environment interacts with a susceptible set of genes to generate an immunological false alarm. Diet has come under increasing scrutiny in recent years. Some studies on type 1 diabetes, for instance, indicate that a Vitamin D deficiency may be involved, while others point to cows milk products in infancy as playing a possible role. The natural food additive carrageenan, derived from seaweed and increasingly used as a thickening agent in some dairy products, has been linked to an increase in the presence of glycosaminoglycans in the body. A 2015 study suggested these naturally occurring complex carbohydrates may be connected to rheumatoid arthritis. The additive is also under scrutiny by the National Institutes of Health for causing gastrointestinal inflammation potentially related to multiple autoimmune disorders. Both carrageenan and gluten, the protein found in wheat and barley that appears to trigger Celiac disease, are among seven types of food additives that have been linked to an overall increase in autoimmune diseases.

A study published in the June 2015 issue of the journal Autoimmune Reviews singles out sodium, glucose, gluten, emulsifiers (such as carrageenan), organic solvents (such as benzene and hexane), nanometric particles and microbial transglutaminase (an enzyme that acts as a protein glue) as increasing susceptibility to autoimmune diseases by damaging the protective barrier in the bowels designed to keep harmful toxins and bacteria out of the bloodstream.

Note that not all of the food additives are industrial in nature. Sugar and salt, for instance, are common ingredients in foods prepared at home. However, even in their most familiar form, sugar and salt help to increase food absorption. Both can take on more industrialized forms in factory-processed foods. And both have been shown, along with the other additives on the list, to increase intestinal permeability resulting in entry of foreign immunological antigens and activation of the autoimmune cascade.

Getting Past the Bodys Defenses

Noting that only a single layer of epithelial cells separates the luminal contents of the intestine from the effector immune cells, the authors detail literally dozens of biochemical stratagems for getting over, under, around and through the intercellular tight junction, a complex network of proteins that modulate movement of fluid, macromolecules and leukocytes from intestinal lumen to the bloodstream and vice versa. Though these potential breaches are collectively known in laymans terms as leaky gut, in some cases what happens is literally a case of reconfiguring the cellular structure of the sentries on duty.

Of most concern, perhaps, is the least predictable category of additive, known as nanometric particles. Initially used in the pharmaceutical industry as encapsulation devices designed to speed drug delivery into the bloodstream, they are increasingly being used in the food industry to enhance the taste and texture of foods. Trouble is, the rules of operation at the nanotechnology level are not well understood.

If an additives absorption into the body is increased substantially by encapsulating it within lipid nanoparticles, then it could exhibit toxic effects that could not be predicted from data obtained on the same material in microscopic or macroscopic form, write the authors, Dr. Aaron Lerner of the Technion-Israel Institute of Technology and Dr. Torsten Matthias of the Aesku-Kipp Institute in Germany. This is particularly true, they note, if the bioactive component is incorporated into a product that is consumed regularly in large volumes, such as artificially enhanced soft drinks or beverages.

In this study each food additive was studied separately using tissue samples in a lab setting. But in reality the interactions between the modern food supply and the human body is much more complex, the authors note, since in nanotechnology many of the additives can be combined.

The diet of the industrialized world is vastly different from what it was even a generation ago, write Lerner and Matthias, with new genetic modifications, chemical ingredients, flavors, preservatives and new nanotechnologies. Over recent decades, a significant increase in the incidence of autoimmune diseases in industrialized countries has led to the postulation that diet is a potential environmental risk factor for such disorders. Although causality has not been proven, increases in the usage of the abovementioned food additives have paralleled increased incidences of autoimmune diseases over the same amount of time.New Diagnostic Tools for An Evolving Dietary Universe

With changes occurring so quickly in the food industry, health professionals can have a hard time dispensing dietary advice. Even when patients have been advised what to look for, knowing what additives lurk in common foods may be increasingly tricky. Take microbial transglutaminase, the so-called meat glue that can turn random hunks of meat into what appears to be steak. According to the USDA, this enzyme is supposed to appear on the ingredient list of meat products, with the term formed meat product appearing on the label. But if meat glue is used in a restaurant or cafeteria which is increasingly the case customers would have a much harder time knowing what exactly they are cutting into.

Another problem facing modern health care professionals is the increasing evidence of overlap between autoimmune disorders. Though specific diseases have traditionally been treated by doctors who specialize in a particular branch of anatomy, the autoimmune cascade can ultimately entangle multiple systems within the body.

Visit link:
Diabetes Health Type 1: Food Additives Linked to Rise in Autoimmune Diseases - Diabetes Health

Read More...

Organisations partner with Shropshire health groups to prevent type two diabetes – shropshirestar.com

March 7th, 2020 2:53 pm

Liva Healthcare and Living Well Taking Control (LWTC) have won the contracts with Shropshire and Telford & Wrekin Clinical Commissioning Groups as part of the Healthier You: NHS Diabetes Prevention Programme (NHS DPP).

Liva Healthcare will offer a digital service to complement LWTCs face-to-face intervention programme.

Type two diabetes is one of the most significant healthcare challenges of our time.

There is strong evidence that its onset can be prevented with an improved diet, an increase in physical activity and successful weight loss.

The Healthier You programme was officially launched in 2016 to support people who have a high risk of developing type two diabetes.

The national roll-out of the NHS DPP programme over the last year has seen face-to-face providers supported by digital partners.

The service from Liva Healthcare and LWTC will be provided free of charge to patients at risk of type two diabetes through a referral from their GP.

About 5,000 patients are expected to be treated across Shropshire, Telford and Wrekin, and Dorset through it latest partnership, over the course of a year.

Liva Healthcare provides patients with access to a free, dedicated, personal health coach.

The regular coaching sessions, through an app, help patients tackle chronic conditions through sustainable lifestyle and behaviour changes.

LWTC is a limited liability partnership between Birmingham-based social enterprise Health Exchange CIC and Exeter-based charity Westbank Community Health and Social Care.

Each organisation has expertise in supporting individuals to change their lives by establishing new patterns of behaviour to improve their health and wellbeing.

The LWTC programme consists of 13 sessions across nine months.

They cover key topics such as understanding the risks of diabetes, behaviour change techniques, healthy lifestyles and mental wellbeing.

Rune Bech, co-founder and UK head of Liva Healthcare, said: We are seeing remarkable results from people going through Livas programme.

"Patients with chronic conditions like obesity, pre-diabetes or type two diabetes have been able to halt or even reverse their conditions simply by providing personal health coaching.

This unique relationship-based approach makes hard-won lifestyle changes long lasting and sustainable.

"By providing a digital solution, the Liva programme is scalable and cost-effective and supports health professionals to drive real change in their communities.

"This new partnership with the NHS and LWTC will help us help even more people live longer and better, which is why we go to work every morning.

Russell Muirhead, clinical director for LWTC said: Were pleased to be named as an NHS Diabetes Prevention Programme provider across Shropshire, Telford and Wrekin.

"Were now busy working in partnership with the local health economy to meet the needs of the local communities from day one.

"This is vital given that over 11,000 people across Shropshire, Telford and Wrekin are at high risk of developing type two diabetes.

"Our focus remains on recruiting passionate local coaches who care about their communities and making a real difference to peoples lives.

Read the original:
Organisations partner with Shropshire health groups to prevent type two diabetes - shropshirestar.com

Read More...

Global diabetic footwear market is projected to reach $ 9.7 billion by 2025 – GlobeNewswire

March 7th, 2020 2:53 pm

New York, March 06, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Diabetic Footwear Market, By Product, By End User, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2025" - https://www.reportlinker.com/p05872172/?utm_source=GNW

Global diabetic footwear market is projected to reach $ 9.7 billion by 2025 on account of rising adoption of diabetic footwear as they are designed to minimize the risk of skin breakdown caused by poor circulation, neuropathy and foot deformities. Moreover, these footwears offer a variety of features like non-binding uppers, stretchable uppers, orthotic support, extra depth design for a pressure-free fit, deep-toe-box, functional soles, and others in order to protect diabetic feet. These designed footwears are mostly used by athletes and common people that are suffering from foot deformities caused by diabetes. Diabetes leads to poor control over blood sugar levels and thus can damage nerves and vessels of feet. Therefore, consumers with diabetes are more likely to have foot problems which are the key factor anticipated to influence the demand for diabetic footwear across the globe in the coming years. Rising prevalence of diabetes and growing disposable income are some of the major factors anticipated to propel the global diabetic footwear market in the coming years. However, the market growth is likely to be negatively affected on account of lack of proper knowledge about using diabetic footwear among potential users as well as low awareness about proper foot care in diabetic patients, particularly in underdeveloped and developing countries. The global diabetic footwear market is segmented based on the product, end-user, distribution channel and region.Based on the product, the market can be segmented into slippers, sandals and shoes.

Among them, the shoe footwear type dominated the market in 2019, and the product segment is expected to maintain its leadership position in the coming years as well which can be attributed to the higher preference of shoes in both men and women. Office going population always prefers wearing shoes since a formal attire includes shoe, which is increasing the demand for these shoes, thereby boosting the growth of this segment in the market. Major players operating in the diabetic footwear market are Podartis S.r.l., American Aetrex Worldwide, Inc., Orthofeet Inc, Drew Shoes (U.S.), Dr. Comfort, DJO Global Inc (U.S.), Dr. Zen Products, Inc. (U.S.), Propet USA, Inc. (U.S.), DARCO International, I-Runner (U.S.), Finn Comfort (U.S.), Pilgrim shoes (U.S.), Hush Puppies Retail, Inc., New Balance, Inc., and others.

Years considered for this report:

Historical Years: 2015-2018 Base Year: 2018 Estimated Year: 2019 Forecast Period: 20202025

Objective of the Study:

To analyze and forecast the market size of the global diabetic footwear market. To classify and forecast global diabetic footwear market based on the product, end-user, distribution channel, company and regional distribution. To identify drivers and challenges for the global diabetic footwear market. To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global diabetic footwear market. To conduct a pricing analysis for the global diabetic footwear market. To identify and analyze the profile of leading players operating in the global diabetic footwear market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of diabetic footwear manufacturers across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers which could not be identified due to the limitations of secondary research. The analyst examined the distribution channels and presence of all major players across the globe. The analyst calculated the market size of global diabetic footwear market by using a bottom-up approach, wherein data for various end-user segments were recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

Diabetic footwear manufacturers, suppliers and other stakeholders Government bodies such as regulating authorities and policymakers Organizations, forums and alliances related to diabetic footwear Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, the global diabetic footwear market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Market, By Product: o Shoes o Sandals o Slippers Market, By End User: o Men o Women Market, By Distribution Channel: o Store-based o Non-store based Market, By Region: o North America United States Mexico Canada o Asia-Pacific China Japan India South Korea Australia o Europe Germany France United Kingdom Italy Spain o South America Brazil Colombia Argentina o Middle East & Africa South Africa Saudi Arabia UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global diabetic footwear market.

Available Customizations:

With the given market data, we offers customizations according to a companys specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).Read the full report: https://www.reportlinker.com/p05872172/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Visit link:
Global diabetic footwear market is projected to reach $ 9.7 billion by 2025 - GlobeNewswire

Read More...

Here is why Tandem Diabetes Care, Inc. (TNDM) stock volatility recorded over the last month was 5.48% – The InvestChronicle

March 7th, 2020 2:53 pm

Tandem Diabetes Care, Inc. (TNDM) is priced at $75.44 after the most recent trading session. At the very opening of the session, the stock price was $75.43 and reached a high price of $76.81, prior to closing the session it reached the value of $77.58. The stock touched a low price of $72.92.

Tandem Diabetes Care, Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the companys stock is recorded $91.65 on 02/20/20, with the lowest value was $51.37 for the same time period, recorded on 04/18/19.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Tandem Diabetes Care, Inc. shares are logging -17.69% during the 52-week period from high price, and 46.86% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $51.37 and $91.65.

The companys shares, operating in the sector of healthcare managed to top a trading volume set approximately around 948399 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Tandem Diabetes Care, Inc. (TNDM) recorded performance in the market was 26.56%, having the revenues showcasing 18.36% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 4.53B, as it employees total of 1043 workers.

During the last month, 9 analysts gave the Tandem Diabetes Care, Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 67.89, with a change in the price was noted +18.90. In a similar fashion, Tandem Diabetes Care, Inc. posted a movement of +33.43% for the period of last 100 days, recording 1,545,246 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for TNDM is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Raw Stochastic average of Tandem Diabetes Care, Inc. in the period of last 50 days is set at 51.19%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 20.97%. In the last 20 days, the companys Stochastic %K was 32.85% and its Stochastic %D was recorded 35.90%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be pessimistic, given the fact the metric is recording 26.56%. Additionally, trading for the stock in the period of the last six months notably improved by 7.83%, alongside a boost of 22.11% for the period of the last 12 months. The shares increased approximately by 7.84% in the 7-day charts and went down by 1.04% in the period of the last 30 days. Common stock shares were driven by 18.36% during last recorded quarter.

Continue reading here:
Here is why Tandem Diabetes Care, Inc. (TNDM) stock volatility recorded over the last month was 5.48% - The InvestChronicle

Read More...

Increasing Demand of Veterinary Medicine Market by 2026 with Top Key Players like Bayer Animal Health, Ceva Animal Healthcare, Elanco Animal Health,…

March 7th, 2020 2:51 pm

Veterinary Medicine Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It also provides market information in terms of development and its capacities.

Get Sample copy of this report @: http://www.a2zmarketresearch.com/sample?reportId=231302

Some of the most influential companies in this Market include: Bayer Animal Health, Ceva Animal Healthcare, Elanco Animal Health, Merck Ltd., Zoetis Animal Healthcare, Virbac S.A. Vetoquinol, Boehringer Ingelheim Vetmedica, Merial Animal Health, Vtoquinol S.A., Novartis Global.

This study provides an evaluation of aspects that are expected to impact growth of market in an undesired or constructive method. The Veterinary Medicine market has been consistently examined with respect to the corresponding market segments. Each year within the mentioned forecast period is concisely considered in terms of produce and worth in the regional as well as the global markets respectively. Technical expansions of the Veterinary Medicine market have been examined by focusing on different technical platforms, tools, and methodologies. The notable feature of this research report is, it incorporates clients demands as well as future progress of this market across the global regions.

Global Veterinary Medicine Market Research objectives:

Get Exclusive Discount on this report @: http://www.a2zmarketresearch.com/discount?reportId=231302

The Veterinary Medicine Market has grown steadily over the last decade and is expected to improve CAGR over the forecast period (2020 2026). It will also be one of the industries influencing global revenue generation. Rapidly growing demand, abundant raw materials, population growth, financial stability, and product awareness are some of the direct and indirect developments in the market.

Market Segmentation: By Product Type

Market Segmentation: By Application

Table of Contents

Global Veterinary Medicine Market Research Report 2020 2026

Chapter 1 Veterinary Medicine Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Veterinary Medicine Market Forecast

Buy Complete Report only @ $2350: http://www.a2zmarketresearch.com/buy?reportId=231302

If you have any special requirements, please let us know and we will offer you the report as you want.

Read more:
Increasing Demand of Veterinary Medicine Market by 2026 with Top Key Players like Bayer Animal Health, Ceva Animal Healthcare, Elanco Animal Health,...

Read More...

Community takes steps to kick canine cancer’s butt – The Tribune – Ironton Tribune

March 7th, 2020 2:51 pm

Shhh! Dont tell. We are having cake Tuesday. It seemed appropriate since we are celebrating. We even designed and ordered shirts: green shirts with a wiggly dog butt. The celebration is a tad bittersweet, but it is a celebration regardless.

Kick Cancers Butt

We put in our chemotherapy hood this fall and have taken our first two patients through their treatment.

While there are hospitals that administer chemotherapy without a chemo/fume hood, it is not safe for the employees nor in compliance with the law. I have stayed away from injectable chemotherapy because of the cost of a hood and safety concerns.

But when Roxy died of her cancer, because the owners could not travel the distance to chemo treatment, I decided I wanted to fight back. A super client (Max Duty) fighting her own medical problems, did some fundraising for us. The fundraising wasnt very successful, but I did find a lot of community support for a chemo program. Sally worked on the regulations and set us up for the install. Lindsay took the chemo care lead and we staffed Tuesdays to be able to do chemo.

Why wait? Aspirate!

I signed up for Dr. Sue Cancer Vet Ettingers lectures at the Midwest Veterinary Conference. She was a dynamic speaker and made me believe that I could make a difference. (She was right.) I attended more of her lectures at the American Veterinary Medical Association Conference.

We started paying more attention to small masses and used her rule of doing more fine needle aspirates on masses. We set up a cytology station to do aspirates more efficiently. Any mass that is present for more than a month and is as big as a pencil eraser should be aspirated and checked.

You cannot tell by palpation (feeling) that a tumor is a fatty tumor or not. (Some of the dangerous tumors, you can tell they are definite tumors that need to be removed.)

See Something, Do Something

Many times, surgery is curative. We had hoped that was the case with Rusty. He had a large intestinal mast cell tumor that before surgery was affecting his quality of life. He was not eating and was sick. We removed a five-centimeter tumor which had several intestinal blood vessels wrapped around it.

After surgery, he felt better for a few weeks, but then was sick and not eating again. His owners chose chemo treatment because they had no other option to try to save him.

Chemo for the Win

Max is finishing up his 16 weeks of Madison Wisconsin chemotherapy protocol for lymphosarcoma. He had first come as a second opinion. His cancer had been diagnosed, but not staged.

He was blind and had a large raw patch on the side of his face. I suspect they were thinking euthanasia was their only option.

Maxs parents were pleased to know that there were options and scheduled him for treatments. At every visit, he had an exam, blood work and his tumors measured. He has had a combination of IV, injection and oral medicine. His last routine visit is Tuesday.

Live Longer, Live Well

Chemo in pets is not like chemotherapy in people. We do not have to get another 10 or 20 years from our protocols. We do not make the pets sick with the medications. We have a medicine kit that we send home with drugs for nausea, vomiting, diarrhea. We try to anticipate any side effects and treat them before they happen.

Between the two dogs with 16 weeks each, they had five days of diarrhea and two days of vomiting. That is not bad. Rusty and Max both improved on their chemo. They both started eating and gained some weight. Max gained a little too much weight and had to be on a diet. Rusty started to nip at us again. Maxs fine needle aspirate cytology came back negative. We seem to be winning!

Sometimes, We Dont Win

Rusty started to decline on the 15th week of treatment.

While I was at the Midwest Veterinary Conference last week, the owners called Lindsay and told her that he was not doing well.

I left my lecture and I called to personally speak with Dr. Duncan, who was covering my emergencies. Well-briefed on Rusty and his owners, Dr. Duncan was prepared to do whatever was needed.

Unfortunately, the best thing seemed to be euthanasia. We were all sad.

I have not been able to connect with the owners since he was euthanatized. I know they will be grieving. Actually, so are we. Still, his owners had an extra five to six months of good life that was important to them.

We are celebrating Max and Rusty. I made a word cloud paw print (Kick Cancers Butt; See Something Do Something; Why wait? Aspirate!; Chemo For The Win: and, Live Longer Live Well), but Lindsays wiggle butt dog with Kick Cancers Butt looked better.

We will mourn Rustys death, but realize that he had more life and better life than he would have.

We miss seeing his parents on Cancer Tuesdays.

It is too soon to tell if Max is in remission or will have to continue a maintenance therapy, but he is certainly doing well and we will pick up our shirts and then celebrate with cake from Daves Bakery.

MJ Wixsom, DVM MS is a best-selling Amazon author who practices at Guardian Animal Medical Center in Flatwoods, Ky. GuardianAnimal.com 606-928-6566

Originally posted here:
Community takes steps to kick canine cancer's butt - The Tribune - Ironton Tribune

Read More...

VCA Animal Hospitals and Lincoln Memorial University Partner to Launch Groundbreaking Veterinary Emergency Medicine Initiative – Business Wire

March 7th, 2020 2:51 pm

CHICAGO--(BUSINESS WIRE)--VCA Animal Hospitals has partnered with Lincoln Memorial University-College of Veterinary Medicine (LMU-CVM) to launch a groundbreaking veterinary emergency medicine initiative that will help students enter careers in veterinary medicine.

The VCA ER Student Scholarship Program is a unique opportunity for five LMU veterinary medicine students to learn in an emergency and specialty care immersion program during their clinical year, as well as an opportunity to advance their veterinary career with VCA.

The competitive scholarship program offers up to $35,000 tuition assistance per student, and a choice of $5,000 for living expenses or a cash bonus. The application process involves an in-person interview with a team led by VCA professionals and preference will be given for students with previous emergency medicine and/or VCA hospital experience. The 4th year clinical rotations include 16 weeks at various VCA hospitals which must be completed immediately prior to graduation. Upon graduation, scholarship recipients must agree to accept an ER position at select VCA hospitals for a three-year commitment. Compensation will be on a production-salary plan.

Collaborations with great veterinary industry partners such as VCA allow LMU-CVM students to obtain excellent clinical experiences and at the same time significantly decrease their student debt load, said Jason Johnson, LMU-CVM Vice President and Dean.

For the four student awardees, this will significantly decrease their debt and at the same time prepare them for their career journey at VCA and beyond. This partnership is in alignment with LMU-CVMs goal to graduate competent, confident, career ready veterinarians.

At VCA, we have always been dedicated to advancing the veterinary profession and encouraging students to pursue studies in veterinary medicine, said Anthony Guerino, DVM, Regional Medical Director for VCA Animal Hospitals. It's a win-win opportunity for everyone. By seeking out and developing the best and brightest veterinary students, we can better serve our patients, while supporting and improving our profession."

Interested applicants should send an introductory letter and CV to Dr. Anthony Guerino at anthony.guerino@vca.com.

About Lincoln Memorial University

Lincoln Memorial University (LMU) is a values-based learning community dedicated to providing educational experiences in the liberal arts and professional studies. The LMU-College of Veterinary Medicine is located on LMUs main campus in Harrogate, Tennessee, with additional academic facilities in nearby Lee County, Virginia. LMU-CVM is an integral part of the Universitys medical programs and provides real-world, community-based education in a collaborative learning environment. For more information about LMU-CVM, call 1.800.325.0900, ext. 7150 or visit us online at vetmed.LMUnet.edu.

About VCA Animal Hospitals

VCA Animal Hospitals operates over 1,000 small animal veterinary hospitals in the U.S., Canada and Japan. The hospitals are staffed by more than 4,500 fully qualified, dedicated and compassionate veterinarians to give pets the very best in medical care, of which over 600 are board certified specialists who are experts in areas such as oncology, cardiology, emergency and critical care, and surgery for animals. VCA Animal Hospitals provides a full range of general practice services to keep pets well and specialized treatments when pets are ill. As part of the Mars, Inc. family of brands, VCA is committed to its purposeA BETTER WORLD FOR PETS.

For more information, please visit VCAhospitals.com or follow on Twitter @vcapethealth and Facebook (facebook.com/VCAAnimalHospitals/).

See the original post here:
VCA Animal Hospitals and Lincoln Memorial University Partner to Launch Groundbreaking Veterinary Emergency Medicine Initiative - Business Wire

Read More...

Brewers and Tasters: Are You Ready? – UC Davis

March 7th, 2020 2:51 pm

Think you need to be a master brewer or ever have brewed at all to enter the Staff Brewing Competition? Think again!

Before my first year, Id never brewed a beer, or even liked beer all that much, said Carlos Barahona, systems architect in the Department of Environmental Science and Policy. Seeing the process and learning what makes beers different helped me find those I like.

And, guess what? Barahona and his Beer Pressure teammates, Eri Furukawa and Joe Schneider, earned the Judges Choice award for best pale ale last year! Schneider is an admissions recruitment specialist in the School of Law. Furukawa worked at the School of Law at the time of last year's competition, but has since moved to the School of Veterinary Medicine where she is an external relations specialist. They are teaming up again this year.

Beyond the brewing, Barahona said, The competition and the event itself introduced me to a lot of staff around campus that I never would have interacted with, and has built friendships with others I knew only professionally before.

Now, as an organizer, hes recruiting teams for the 2020 competition. In addition, tickets are on sale for the tasting event to be held from 5 to 8 p.m. Friday, April 24.

The competition is for UC Davis affiliates only from the Davis or Sacramento campuses or outlying locations while the tasting event is open to all (minimum age 21).

This years brewing categories are porter,hazy NEIPA (New England India pale ale) and cider. Another one of the organizers, Lina Layiktez, director of Conference and Event Services, said ciders are a tasters favorite: They are really easy to drink, and for people who dont really like beer, they are a nice option that allows them to participate in the event along with a significant other or friends who do love beer.

Read more about the 2020 brewing categories.

Admission to the tasting event will include a souvenir glass and up to 24 2-ounce samples. Tasters will be invited to vote for the Peoples Choice Award.

Teams must comprise at least two people and no more than six. Each participant can be on one or two teams (but, if youre on two teams, they must brew different styles). Each style is limited to 15 teams, and each team can submit one or two brews.

To be eligible for awards, competitors must attend the tasting event and serve their brews. Brewers are advised to plan accordingly when figuring how mush beer or cider to make.

The team fee is $10 per brewing submission. Register here by March 24.

Team fees do not include the per person entry fee for the tasting and event. Each team member must register separately at the discounted price of $10.

The tasting event will be held at the Buehler Alumni Center, and food vendors will be on site.

Admission for noncompetitors is $15 for staff, faculty and members of the Cal Aggie Alumni Association, $20 for others. (All guests are on their own for food.) All fees go toward the cost of the facility, tasting glasses and prizes for the best brews.

Register for the tasting event here; deadline April 10.

Follow Dateline UC Davis on Twitter.

Follow this link:
Brewers and Tasters: Are You Ready? - UC Davis

Read More...

Nationwide receives top honor – Insurance Business

March 7th, 2020 2:51 pm

Nationwide, the largest provider of pet health insurance in the US, has been named a Human-Animal Bond Certified Company by the North American Veterinary Association (NAVC) and the Human Animal Bond Research Institute (HABRI), joint founders of the Human-Animal Bond Certification program.

Nationwide has earned this meaningful recognition through its significant commitment to human-animal bond research, education, and professional development, said Steven Feldman, executive director of HABRI. Being a Human-Animal Bond Certified Company recognizes that Nationwide is strengthening the human-animal bond as a core part of its mission.

As part of the certification process, all Nationwide pet associates will complete human-animal bond training, which will educate them about the science behind human-animal bonding and how that science supports pet health and the practice of veterinary medicine.

Becoming Human-Animal Bond certified is an honor and a process that we are committed to in every interaction we have with pets and their families, said Heidi Sirota, Nationwides chief pet officer. We know the more we learn, the more we can protect them.

Nationwide has made sizeable investments in independent research on the benefits of companion animals for veterans with PTSD, people with autism, and cancer patients. The company has also conducted research on the benefits of pet-friendly workplaces.

Nationwide is committed to protecting our members pets though our direct relationships with pet owners and through our veterinary partners, said Dr. Jules Benson, Nationwide associate vice president of veterinary relations. That is why we are so proud to support human-animal bond research. Understanding and sharing the science of the human-animal bond helps all of us as individuals, families and communities.

Here is the original post:
Nationwide receives top honor - Insurance Business

Read More...

Feline frenzy on tap this weekend at Illini Cat Club’s 28th show – Champaign/Urbana News-Gazette

March 7th, 2020 2:51 pm

URBANA For area cat-lovers, here is an event you wont want to miss.

The Illini Cat Club will host its 28th All-Breed Cat Show on Saturday and Sunday, showcasing around 30 different breeds and some of the countrys top cats, including Maine coons, Bengals, Ragdolls, Cornish Rexes and exotics, among others.

We do it as a fundraiser and to increase awareness of pedigreed cats and to show were not all just about breeding. We are about the benefit of all cats, said local cat judge Mary Auth, who will be among those officiating at the show.

Held at the Radisson Hotel (1001 W. Killarney St., U), doors are open from 10 a.m. to 4 p.m. Saturday and 9 a.m. to 3 p.m. Sunday, with an admission donation of $6 for adults and $5 for children. Children under 3 get in free.

The two-day event will feature an agility competition, rescue groups with information booths and vendors with cat-related items for sale.

The University of Illinois College of Veterinary Medicine which has been working on a research project funded by the WYNN Foundation to develop surgical techniques for cats and dogs with short faces will also have a presence.

In addition to being a judge, Auth is also secretary for the Illini Cat Club. She has held many other positions during the clubs 40 years.

Im the only original member left, she said.

The club formed in 1980 when a few locals bonded over their love of cats.

Some were showing cats in Chicago and wanted to bring that experience to Champaign-Urbana. Minus a nine-year hiatus, the show has been a staple ever since.

Cats available for adoption can also compete in the show, and historically, weve adopted just about every cat weve brought, Auth said.

Auth also said the club will be collecting cat and dog food at the door that will be donated to the Eastern Illinois Foodbank.

People who need food, if they have pets, we want to make sure the pets are taken care of, too, she said.

While research shows the Cat Fanciers Association, the worlds largest registry of pedigreed cats, is growing worldwide, it is getting smaller in the United States, mainly due to high show costs, an aging population, lack of commitment to a breeding program and stricter breeding laws.

We used to have 350 cats at a show, and now were lucky if we get 150 or 160, Auth said.

But for her, nothing beats the camaraderie.

Thats one of the neatest things about cats, and animal lovers in general, Auth said. All around the world, youve got a friend.

Go here to read the rest:
Feline frenzy on tap this weekend at Illini Cat Club's 28th show - Champaign/Urbana News-Gazette

Read More...

Worlds First Cloned Cat CC Lived Long, Normal, Happy Life Before Her Death – CBS Dallas / Fort Worth

March 7th, 2020 2:51 pm

COLLEGE STATION, Texas (CBSDFW.COM) The worlds first cloned cat named Copy Cat or CC for short, has passed away at the age of 18 after veterinarians diagnosed her with kidney failure.

(credit: Larry Wadsworth/Permission of Texas A&M College of Veterinary Medicine & Biomedical Sciences)

CC passed away on March 3 in College Station, the same place where her life began as a result of groundbreaking cloning work, according to Megan Myers, Texas A&M College of Veterinary Medicine & Biomedical Sciences.

She was born Dec. 22, 2001, and was adopted by Dr. Duane Kraemer, a senior professor in the colleges Reproduction Sciences Laboratory, and his wife, Shirley, six months after her birth.

We in the CVM are saddened by the passing of CC. As the first cloned cat, CC advanced science by helping all in the scientific community understand that cloning can be effective in producing a healthy animal, said Dr. Eleanor M. Green, the Carl B. King dean of veterinary medicine at Texas A&M.

While she lived a long, normal, and happy life, CC was extraordinary in what she represented to the Kraemers, the CVM, and science as a whole, Green said. The entire CVM community mourns her loss, as all at Texas A&M cared deeply about her as a member of the Aggie family, and especially for the Kraemers, for whom CC was a beloved pet for 18 years.

CCs story began with Dr. Mark Westhusin, a CVM professor and the principal investigator of the Missyplicity Project, a $3.7 million effort to clone a mixed-breed dog named Missy that was owned by John Sperling, founder of the University of Phoenix.

When the news of the project spread, people around the country became interested in saving pets tissues that could possibly be used for cloning in the future. This demand resulted in the establishment of Genetic Savings and Clone (GSC), Inc., led by Sperlings colleagues Lou Hawthorne and Dr. Charles Long.

While GSC became a bank for these tissues, Westhusin and his team at Texas A&M began to explore the cloning of other pet species, specifically cats.

CC was produced using nuclear transfer of DNA from cells that were derived from a female domestic shorthair named Rainbow.

Once it was clear the nuclear transfer was successful, Kraemer and other scientists transferred the embryos into a surrogate mother, who gave birth to a healthy kitten about two months later.

Though the cats were identical on a genetic level, developmental factors led them to have slightly different coat patterns and color distributions.

CCs passing makes me reflect on my own life as much as hers, Westhusin said. Cloning now is becoming so common, but it was incredible when it was beginning. Our work with CC was an important seed to plant to keep the science and the ideas and imagination moving forward.

CC also became one of the first cloned cats to become a mother. When CC was five years old, she gave birth to three kittens that lived with her for the rest of her life in a custom, two-story cat house in the Kraemers backyard.

CC was the biggest story out of A&M ever and still is, as far as international reach is concerned, Kraemer said. Every paper and magazine had pictures of her in it. She was one of the biggest accomplishments of my career.

While CC represented a great advancement in genetic research, to the Kraemers, she was also a beloved pet. She will be missed by them especially, but also by those at the CVM, Texas A&M and beyond who have followed her story since birth.

CC was a great cat and a real joy, Kraemer said. She was part of the family and very special to us. We will miss her every day.

Throughout her lifetime, CC regularly made news for her birth, pregnancy and each birthday. She proved to the world that cloned animals can live the same full, healthy lives as non-cloned animals, including being able to produce healthy offspring.

Before CC, no pet had ever been successfully cloned with 100% genetic identity.

The research that led to CCs birth kickstarted a global pet cloning industry led by ViaGen Pets, which today clones cats for $35,000 and dogs for $50,000.

Though CC was the first successfully cloned pet, Texas A&M has gone on to clone more species than any other institution in the world, including horses, pigs, goats, cattle and deer.

Read more:
Worlds First Cloned Cat CC Lived Long, Normal, Happy Life Before Her Death - CBS Dallas / Fort Worth

Read More...

Coronavirus and Your Dog: No Need to Panic Yet – The New York Times

March 7th, 2020 2:51 pm

Hong Kong authorities on Wednesday updated their reports on the lone dog that appears to have a low-grade infection from coronavirus, saying its likely a case of a human transmitting it to the dog.

A spokesman for the governments Agriculture, Fisheries and Conservation Department said the dog, which has been tested several times, is still under quarantine but is not sick.

More than 3,000 people have died from the virus as it spreads around the globe.

But you should not be worried about the welfare of your pets, or other peoples pets, according to authorities.

Both the Centers for Disease Control and Prevention as well as the World Organisation for Animal Health have issued advisories saying there is no evidence that companion animals can spread the virus. Therefore, there is no justification in taking measures against companion animals which may compromise their welfare, the animal health organization said.

Apart from maintaining good hygiene practices, pet owners need not be overly concerned and under no circumstances should they abandon their pets, the government of Hong Kong said. It did suggest that if members of a family were sick with the virus, they might want to consider quarantining their pets.

Heres what has happened so far. A coronavirus patient in Hong Kong had a dog, and the authorities tested the dog which showed some level of virus in its nose and mouth. Theyve tested it several times, and the test still show a weak positive. The dog will remain in quarantine, the authorities said, until its tests are negative.

What does that mean?

Raymond R.R. Rowland, a veterinarian who is a specialist in swine viruses at Kansas State University, said so-called weak positives often show up in testing pigs, where a farmers livelihood can be at stake.

Ill tell you what I tell them, he said. Wait and see.

Even if there is a low-level infection, he said, That doesnt say the animal is sufficiently infected that it can spread the virus. It may be a dead-end host, neither becoming ill nor infecting any other people or animals.

Edward Dubovi, a professor at the Cornell University College of Veterinary Medicine, who worked with a team that identified canine influenza in 2005, said the Hong Kong dog may indeed have a low-level infection, which would not be a big surprise. Humans do pass on infections to their pets and other animals on occasion, he said.

Usually, in those situations, he said, you have an initial infection and it doesnt go anywhere else.

Nonetheless, he said, stopping transmission to animals of any virus is always wise, so anyone who has the virus should treat their pets as they would family members, to try to prevent transmission, limiting contact, wearing a mask, washing hands often.

Of course with dogs, he said, that can be tough. Ive probably had my hands licked 19 times since lunchtime, he said, of his own dogs.

Go here to see the original:
Coronavirus and Your Dog: No Need to Panic Yet - The New York Times

Read More...

Doctors need to embrace the ‘power of yet’ – STAT

March 7th, 2020 2:51 pm

I believe in the power of yet. Doctors should, too, especially the one who used my daughters case as grist for a short-sighted article without her permission.

The power of yet is a concept promoted by Stanford psychologist Carol Dweck as part of her research on the differences between growth and fixed mindsets. It tells us that there is always room to learn and to grow through practice, discovery, and research. There is or at least there should be a lot of yet involved in medicine, especially when it comes to diagnosing and treating tick bites.

Back in 2008, my daughter and I were apprentice bird banders. We were both bitten by ticks in the woods around Hopewell, New Jersey, despite taking precautions. I was lucky enough to get the classic bulls eye-rash, suggesting that I had Lyme disease. She pulled two ticks from her abdomen that were not engorged and had been attached for less than eight hours.

advertisement

We both took antibiotics for four weeks. I got better. She has been sick ever since: mostly bedridden for two years, she lost weight, lost hair, and developed postural orthostatic tachycardia syndrome an uncomfortable rapid increase in the heart rate when standing up after sitting or reclining. Open sores periodically erupted on her legs and then mysteriously disappeared, which were dismissed as nothing by her primary doctor and two dermatologists.

I stepped away from working as a researcher and news editor to become her caregiver. I put my Ph.D. to work to find the right doctors and treatment protocols, though the well was pretty dry.

Fast forward 10 years to an appointment with Warren R. Heymann, a New Jersey dermatopathologist, to get a better understanding of, or diagnosis for, my daughters condition. After he completed his examination, he suggested that she come back for a second visit when she had a fresh sore so he could biopsy it; otherwise, he had nothing to offer.

Before we left his office, I pointed out the long white lines behind my daughters knees, lines that look like the stretch marks that women often see during and after pregnancy.

I tried to employ the growth mindset, the power of yet approach. See these marks? I asked Heymann, pointing to the white lines technically called striae that had appeared years before as angry red streaks. I told him that such lines are commonly seen in people with bartonellosis, a variety of diseases caused by infection with Bartonella, a group of bacteria transmitted by ticks, fleas, and other vectors.

I could tell almost immediately that he dismissed what I was saying.

I didnt know quite how much he dismissed what I had said until his two-year old essay, Striae Due to Bartonella is a Stretch recently landed in my email inbox. My power of yet approach had no effect.

The story he told sounded like it could be you and your daughter, a friend wrote.It was. In the article, Heymann recounted our conversation about my daughter, which had occurred just two weeks before he published his opinion piece in DW Insights and Inquiries, an online publication of the American Academy of Dermatology. (He didnt ask permission to use this example. I tried to submit a rebuttal to the American Academy of Dermatology, but its journals seem to accept submissions only from members.)

Heymann found an article published in the journal Parasites and Vectors by Ricardo Maggi, co-director of the Intracellular Pathogens Research Laboratory at North Carolina State University School of Veterinary Medicine, and colleagues that addresses these striae. Heymann dismissed their work. Although he acknowledged that no one knows what causes these marks, he conjectured that they occur when excessive stretch overwhelms the dermal integrity of the skin, resulting in a woundtype response with abnormal and/or incomplete repair. Not exactly a power of yet response.

Maggi works with Ed Breitschwerdt, a doctor of veterinary medicine and the man I call the Bartonella guru. He has been studying Bartonella since the death of his father and, more recently, the death of his mother, both likely from Bartonella infections. Breitschwerdt calls Bartonella a stealth pathogen. He and others working to understand tick infections have learned that individuals infected with Bartonella exhibit red striae, now referred to as Bartonella tracks. They dont know why yet.

Heymann overlooked the work of Marna Ericson, an assistant professor of dermatology at the University of Minnesota School of Medicine, who is also trying to determine what causes these tracks in people infected with Bartonella. Her research began when her son developed them. (Ericson happens to be the second author on the Maggi paper that Heymann targeted.)

The dermatopathologist invoked Kochs postulates, four criteria that scientists use to identify agents that cause disease, to dismiss Bartonella as a cause of the stretch marks. Even if confirmed by other studies, an association does not equate with causation this was not a fulfillment of Kochs postulates, he wrote.

Not so fast. Breitschwerdt, who has written about the limitations of Kochs postulates, says it is difficult to apply them when attempting to attribute disease causation to stealth pathogens that can induce chronic, slowly progressive disease manifestations in an animal or human patient. The postulates also dont let researchers readily address environmental, nutritional, genetic and other relevant factors that influence disease causation and do not consider the pathogenic complexities induced by sequential or simultaneous infection with more than one pathogenic microorganism.

Frustrated by Heymanns dismissal, I posted a photo of my daughters sores (with her permission, of course) to an Internet discussion group I belong to called MMI: Microbes and Mental Illness. This 20-year-old closed group, funded and moderated by Robert Bransfield, a New Jersey psychiatrist, has 750 members from 20 countries: psychiatrists and other physicians, nurses, other clinicians, and researchers interested in understanding the association between microbes and mental illnesses.

One of the MMI members, a nurse practitioner who treats a large Amish population in Pennsylvania, suggested that my daughter be tested for Francisella tularensis, a species of bacteria that causes tularemia (also known as rabbit fever), since her sores resembled those she saw in hunters who spend time in the woods. Sure enough, my daughter tested positive for it. And sure enough, tick bites are one way this pathogen can be transmitted.

What I hope readers, especially Warren R. Heymann, take away from this essay is that the power of yet is an inherent concept in the practice of medicine. Doctors must be open to new knowledge, absorb it, and synthesize it.

Physicians dismissed Joseph Lister when he came to America to talk about sterile surgeries, though he was right. They dismissed Ignaz Semmelweis when he suggested that physicians change their clothes and wash their hands before delivering babies and he, too, was right.

The fashion today is to dismiss those trying to understand illnesses for which we dont have answers, like tick-borne infections, as Heymann did. But when he wrote, it must be acknowledged that the concept of these chronic infections is controversial, he was on to something. Chronic infections caused by tick bites are controversial only because we dont completely understand them yet.

Sue Ferrara, Ph.D., a former researcher and editor for ABC News, is an elected school board member in New Jersey, where she learned about the power of yet. She is writing as a private citizen.

Visit link:
Doctors need to embrace the 'power of yet' - STAT

Read More...

WSU research could help stop herpesvirus before infection – WSU News

March 7th, 2020 2:51 pm

Members of the Nicola Laboratory (left to right) Tri Komala Sari, Seth Schneider, Anthony Nicola, Katrina Gianopulos and Becky Lee review data outside of the lab.

By Josh Babcock, College of Veterinary Medicine

The scientific community may be one step closer to stopping the spread of the herpes virus thanks to new Washington State University research.

Herpes simplex virus type 1 (HSV-1) is the most common cause of oral herpes which causes painful blisters better known as cold sores.

WSU researchers recently published a study in the American Society for Microbiologys journal mSphere that is the first to identify how one of the virus proteins acts as a critical signaler for the virus to succeed in infecting a cell.

Herpes simplex virus type 1 invades the body through the epithelial cells that line human organs, including the skin. Once inside, the attack sequence is launched when a protein on the virus surface called glycoprotein C detects a change in the cells acidity level. A second protein called glycoprotein B then initiates the attack on the cell. We may have identified a novel target for intervention because, in theory, if you can prevent that initial infection, you can avoid the virus, said Tri Komala Sari, a WSU graduate student in the Department of Veterinary Microbiology and Pathology and the papers lead author.

Komala Sari said while the virus was able to invade the cell without glycoprotein C, it was significantly delayed in recognizing the change in acidity levels and it wasnt as effective in taking over the cell.

Understanding the function of this protein could help researchers learn how to keep the virus from invading a cell or lower its efficiency during infection.

According to the Centers for Disease Control and Prevention, HSV-1, the oral form of herpes, infected 47.8% of Americans ages 14 to 49 from 2015 to 2016. The World Health Organization estimates 3.7 billion people under age 50 (67%) have HSV-1 globally. There is no vaccine for the virus. To make matters worse, many people infected dont show any symptoms.

After that initial infection the virus hides. Thats why they say, herpes is forever, because once you get that latent infection there is no way back from that, said Anthony Nicola, the G. Caroline Engle Distinguished Professor of Infectious Diseases and principal investigator on the project.

Nicola said understanding how the virus infects the cell may help uncover ways to stop the virus before it goes into hiding. He noted the herpesvirus is far more complex in structure than other viruses. While the herpes virus has about a dozen proteins on its surface with various functions, HIV and influenza have just two or three proteins.

Komala Sari said theres still a long way to go in blocking the virus, but this finding could be a target of a vaccine in the future.

Now we need to know more about how that interaction between these two proteins occurs, when and where, she said.

The work was funded by a grant from the National Institutes of Health.

See original here:
WSU research could help stop herpesvirus before infection - WSU News

Read More...

Leading Medical Insurer for Pets Confirms Their Data Shows No Unusual Changes in Frequency of Illness over the Last 45 Days – marketscreener.com

March 7th, 2020 2:51 pm

SEATTLE, March 01, 2020 (GLOBE NEWSWIRE) -- Trupanion, a leading provider of medical insurance for cats and dogs, confirmed today that they have seen no unusual increase or change in the frequency of illnesses in their extensive pet health database. The Seattle-based pet company, now in its third decade, has paid out over $1 billion in veterinary invoices and is constantly reviewing data to monitor changes in veterinary medicine to understand any underlying changes related to regular illness patterns.

Vice President of Analytics, Mary Rothlisberger confirmed: We monitor our data on a very granular level; daily, weekly and monthly and by breed, country, city and even at a neighborhood level to make sure we understand and are on top of any health-related trends that might be out of the norm. As of today, we have not seen any increases or changes in the frequency of illnesses that would appear unusual.

Dr. Steve Weinrauch, BVMS, MRCVS, Trupanions Chief Veterinary Officer explained: With the recent news regarding a pet dog in Hong Kong being quarantined after testing 'weak positive' for COVID-19, we have experienced increasing concern from our members regarding the health of their pets. We want to provide them and other loving pet owners with some peace of mind. We understand that a pet is a member of the family and its natural to be worried for all of your loved ones.

The U.S Centers for Disease Control and Prevention (CDC) have further confirmed that no animals in the United States have been identified with the virus and there is no evidence to suggest that dogs, or other pets can contract or spread COVID-19.

Just as it has for the last 20+ years, Trupanion wants to continue to reassure existing or new members that coverage includes any medical issues that occur after enrollment and that our team is on hand 24/7 to support any questions they may have.

Weinrauch continues: It is important to Trupanion that we make sure everyone has the latest information in terms of what we see show up in our data. If things do change, we will be letting members, pet owners and veterinarians know immediately. In the meantime, as always, if theres ever anything that youre worried about and you notice your pet acting under the weather, you should visit your trusted veterinarian.

Interviews available

Trupanion's Chief Veterinary Officer, Dr. Steve Weinrauch, BVMS, MRCVS and Vice President of Analytics, Mary Rothlisberger, ACAS are always available to share insights or to provide context regarding pet health data as it relates to the extensive Trupanion database of over half a million pets. Please contact mediarelations@trupanion.com for scheduling.

Helpful sources of informationhttps://www.avma.org/blog/what-do-you-need-know-about-coronavirushttps://www.avma.org/sites/default/files/2020-02/AVMA-Human-Coronavirus-Summary.pdfhttps://www.avma.org/sites/default/files/2020-02/AVMA-Coronavirus-Taxonomy-Notes.pdfhttps://www.avma.org/sites/default/files/2020-02/AVMA-Detailed-Coronoavirus-Taxonomy-2020-02-03.pdf

About Trupanion

Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada with over 500,000 pets enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance with unlimited payouts for the life of their pets. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. For more information, please visit trupanion.com.

Contact:

MediaMichael Nankmichael.nank@trupanion.com206.436.9825

InvestorsLaura Bainbridge, Head of Investor RelationsInvestorRelations@trupanion.com206.607.1929

Read more from the original source:
Leading Medical Insurer for Pets Confirms Their Data Shows No Unusual Changes in Frequency of Illness over the Last 45 Days - marketscreener.com

Read More...

Page 670«..1020..669670671672..680690..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick